Search research articles
Contact Us
Filters
Showing results (491-500 of 559) with videos related to
Page
of 56
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
October 21, 2021
Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency department
Evan J Beck, Yu-Hsiang Hsieh, Reinaldo E Fernandez, et al.
Journal of Clinical Microbiology
|
January 19, 2022
Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department
Evan J Beck, Yu-Hsiang Hsieh, Reinaldo E Fernandez, et al.
BMC Immunology
|
February 17, 2022
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 17, 2021
Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2
Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
Vox Sanguinis
|
September 14, 2022
Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility
Arwa Z Al-Riyami, Lise Estcourt, Naomi Rahimi-Levene, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 26, 2025
Guidance on the management of asymptomatic blood donors who test positive for Babesia
Evan M Bloch, Jeremy W Jacobs, Edouard Vannier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2023
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
Evan M Bloch, Daniele Focosi, Shmuel Shoham, et al.
Vox Sanguinis
|
February 12, 2021
ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 Working Group
Ruchika Goel, Evan M Bloch, France Pirenne, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 30, 2020
SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy
Harini Natarajan, Andrew R Crowley, Savannah E Butler, et al.
The Journal of Clinical Investigation
|
August 9, 2020
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
Sabra L Klein, Andrew Pekosz, Han-Sol Park, et al.
Page
of 56
Search research articles
Search
Showing results (491-500 of 559) with videos related to
Sort By:
Page
of 56
Medrxiv : the Preprint Server for Health Sciences
|
October 21, 2021
Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency department
Evan J Beck, Yu-Hsiang Hsieh, Reinaldo E Fernandez, et al.
Journal of Clinical Microbiology
|
January 19, 2022
Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department
Evan J Beck, Yu-Hsiang Hsieh, Reinaldo E Fernandez, et al.
BMC Immunology
|
February 17, 2022
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 17, 2021
Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2
Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
Vox Sanguinis
|
September 14, 2022
Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility
Arwa Z Al-Riyami, Lise Estcourt, Naomi Rahimi-Levene, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 26, 2025
Guidance on the management of asymptomatic blood donors who test positive for Babesia
Evan M Bloch, Jeremy W Jacobs, Edouard Vannier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2023
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
Evan M Bloch, Daniele Focosi, Shmuel Shoham, et al.
Vox Sanguinis
|
February 12, 2021
ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 Working Group
Ruchika Goel, Evan M Bloch, France Pirenne, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 30, 2020
SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy
Harini Natarajan, Andrew R Crowley, Savannah E Butler, et al.
The Journal of Clinical Investigation
|
August 9, 2020
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
Sabra L Klein, Andrew Pekosz, Han-Sol Park, et al.
Page
of 56